OAM
TBIO

Ophir Asset Management’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Ophir Asset Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-73,028
Closed -$7.06M – 41
2022
Q1 		$7.06M Buy
73,028
+22,081
+43% +$3.35M 1.08% 28
2021
Q4 		$9.9M Buy
50,947
+14,218
+39% +$2.21M 1.19% 27
2021
Q3 		$7.36M Buy
+36,729
New +$9.32M 1.02% 33

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ophir Asset Management's TBIO Position: Q2 2022 in Review

Ophir Asset Management sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2022, closing a stake of 73,028 shares — an estimated $7.06M sold.

Ophir Asset Management first reported a position in TBIO in Q3 2021 and held it in 3 quarters. The position peaked at $9.9M in Q4 2021. 37 funds tracked by Wall St. Rank hold TBIO as of Q2 2022.

  • Ophir Asset Management reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Ophir Asset Management sold 73,028 Telesis Bio, Inc. Common Stock shares in Q2 2022, an estimated $7.06M.
  • Ophir Asset Management first reported a position in Telesis Bio, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Ophir Asset Management's Telesis Bio, Inc. Common Stock position peaked at $9.9M in Q4 2021.
  • 37 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2022.

Based on Ophir Asset Management's 13F filing for Q2 2022, filed 26 Jul 2022.